The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.

Celltrion reviews Lotte Biologics production plan amid 434.3 billion won CMO deal

Nov 5, 2026 02:26 (5h ago)

Verifying

Celltrion is reviewing a plan to entrust Lotte Biologics with biopharmaceutical production.
434.3 billion won, approximately $323.5 million, is the value of a new CMO deal.
Celltrion is known to be the client behind the contract manufacturing agreement.